GSE193832
Disruption of dNTPs Homeostasis by Ribonucleotide Reductase Hyperactivation Overcomes AML Differentiation Blockade II
We assessed global gene expression changes in nelarabine (NEL)-treated AML cell lines (U937 and KG1A) Overall design: Expression profiling data in NEL-treated cells (4 replicates) were compared to vehicle (VEH) control cells (4 replicates) by RNA sequencing